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Background: The pattern and factors influencing the lung function recovery in the first postoperative days are still
not fully elucidated, especially in patients at increased risk.
Methods: Prospective study on 60 patients at increased risk, who underwent a lung resection for primary lung
cancer. Inclusion criteria: complete resection and one or more known risk factors in form of COPD, cardiovascular
disorders, advanced age or other comorbidities. Previous myocardial infarction, myocardial revascularization or
stenting, cardiac rhythm disorders, arterial hypertension and myocardiopathy determined the increased cardiac risk.
The severity of COPD was graded according to GOLD criteria. The trend of the postoperative lung function recovery
was assessed by performing spirometry with a portable spirometer.
Results: Cardiac comorbidity existed in 55%, mild and moderate COPD in 20% and 35% of patients respectively.
Measured values of FVC% and FEV1% on postoperative days one, three and seven, showed continuous improvement,
with significant difference between the days of measurement, especially between days three and seven. There was no
difference in the trend of the lung function recovery between patients with and without postoperative complications.
Whilst pO2 was decreasing during the first three days in a roughly parallel fashion in patients with respiratory, surgical
complications and in patients without complications, a slight hypercapnia registered on the first postoperative day was
gradually abolished in all groups except in patients with cardiac complications.
Conclusion: Extent of the lung resection and postoperative complications do not significantly influence the trend of
the lung function recovery after lung resection for lung cancer.
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Patient’s fitness for the planned extent of lung resection
for non small cell lung cancer (NSCLC) represents one
of the main elements of the preoperative selection [1].
Currently, the preoperative lung function assessment
is focused to the prediction of postoperative ventilatory
function and to the estimate of cardiorespiratory reserve.
Numerous studies evaluated late effects of lung resec-
tion (3–6 months after surgery), related to quality of
life, length of survival and exercise tolerance. It is now* Correspondence: profsubotic@gmail.com
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article, unless otherwise stated.established that predicted postoperative FEV1 (ppoFEV1)
is accurate in predicting FEV1 3–6 months after surgery,
but in the same time it is likely to overestimate the FEV1
in the initial post-operative days, when, in fact, most com-
plications occur. It was recently demonstrated that, on the
first post-operative day after lobectomy, for example, the
measured FEV1 may be 30% lower than predicted [2]. Fur-
thermore, in most of the studies of this type, patients with-
out major comorbidity are analysed together with high
risk patients.
That is the reason why the aim of this study was to
analyze trends of the lung function changes in patients
at risk in the immediate postoperative course, regardless
of the presence and type of postoperative complications.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Prospective study on 60 patients at increased risk, who
underwent a lung resection for primary non-small cell
lung cancer in a recent one year period.
Inclusion criteria: complete resection and one or more
known risk factors in the form of COPD, cardiovascular
disorders, advanced age, or other comorbidities.
Preoperative assessment
Preoperative lung cancer staging was done in a usual
manner.
Cardiological evaluation consisted of physical examin-
ation, ECG, echocardiography and/or coronarography
according to need as suggested by current recommen-
dations [3]. Previous myocardial infarction, myocardial
revascularization or stenting, cardiac rhythm disorders,
arterial hypertension and myocardiopathy determined
the increased cardiac risk.
Other associated comorbidities were registered as dia-
betes, thyroid or other endocrinological disorders, per-
ipheral vascular disease, chronic renal insufficiency,
previous cerebrovascular infarctions and nutritional sta-
tus. The latter was expressed as body mass index (BMI)
with cut off value of <18 and >30 for malnutrition and
excessive obesity respectively.
Preoperative lung function testing consisted of standard
spirometry (FEV1, VC, Tiffeneau index, FEF50, FEF25),
measurement of diffusion with determination of transfer
factor (DLCO) and diffusion coefficient.
In COPD patients, respiratory function tests were per-
formed before and after combined bronchodilator ther-
apy. The best measured values were taken as baseline
for the calculation of postoperative FEV1. The severity of
COPD was graded according to GOLD criteria [4] The
existence and extent of bullous emphysema was assessed
based on measurement of the lung tissue density on high
resolution CT.
In patients with moderate COPD and/or DLCO <70% and
anticipated pneumonectomy, perfusion lung scintigraphy
was done in order to calculate the predicted postoperative
FEV1 (ppoFEV1). In these patients, ppo FEV1% was calcu-
lated on the basis of preoperative FEV1% and percent per-
fusion of remaining lung [5]. If the high resolution CT
revealed bullous emphysema either in the tumour bearing
or other lobes, perfusion lung scintigraphy was done as
well, even before lobectomy. In that case, calculation of the
ppoFEV1 was done by using a stepwise method [6]:
ppoLoss in FEV1 ¼ preop:FEV1x % perfusion of the
Tu bearing lung x n=n1
ppoFEV1 ¼ preopFEV1–ppoLoss in FEV1
n: number of segments to be resected; n1: total num-
ber of segments of the diseased lungIn all candidates for lobectomy, calculation of ppo-
FEV1 was done by using Nakahara formula [7] that in-
cludes the number of obstructed lung segments, with
additional calculation by using a perfusion lung scintig-
raphy, if associated COPD existed, as described above.
The COPD index was calculated as sum of decimal
values of FEV1% and FEV1%/FVC% [8].
In patients at increased cardiac risk, either isolated, or
associated with COPD, oxygen consumption was deter-
mined on ergometer bicycle (system VIASYS Master
Screen CPX) according to institutional protocol. During
this test, continuous registration of lung ventilation,
heart rate, and arterial tension at rest and during the ef-
fort was done. The incremental load increase consisted
of 20 W increase each 3 minutes until the submaximal
load was acheved as manifested by submaximal heart
rate, switching to the anaerobic metabolism (RER >1) or
critical decrease of respiratory reserve. The test was
aborted in case of severe dyspnea, retrosternal pain, ver-
tiginous symptoms, severe claudications or abrupt arter-
ial pressure rise. A cut off value of 15 ml/kg/min was
accepted as a lower limits for safe pneumonectomy and
lobectomy., with values <10 ml/kg/min being prohibitive
for any anatomical resection.
Operative procedure
In all patients lung resections were performed through
open approach - muscle sparing thoracotomy with ex-
tension to full posterolateral thoracotomy according to
the need. Incomplete or absent fissures were divided
with stappling devices. Bronchial staplers were used for
lobectomy, whilst manual bronchial closure was the
standard technique for pneumonectomy. Systematic
lymphadenectomy was done in all patients. Two chest
tubes under active suction (20 cmH2O) were routinely
used with successive removal between the 3th and 7th
postoperative days.
All patients underwent postoperative respiratory re-
habilitation according to institutional protocol (inhalation
with secretolitics and/or bronchidlators, forced breathing,
early mobilization). In case of imminent athelectasis, with
radiographic aspect of mediastinal displacement towards
the operated side, intensified physiotherapy was the first
step, followed by bedside fiberbronchoscopic aspiration
after 24 hours at maximum, in case of treatment failure or
progression of athelectasis.
In addition to the usual policy of two chest tubes as-
piration after lobectomy, in some patients with well de-
veloped fissures, only one chest tube is used. After
pneumonectomy, 24 h underwater-seal chest tube drain-
age is a standard institutional practice.
The existence of postoperative air leak is confirmed by
the presence of air-bubbles within a drainage bottle with
the chest tube under active aspiration. In such patients,
Table 1 Patient characteristics
n %
Sex (M/F) 42/18 70/30
Smoking habits (ns, fs, cs) 8/13/39 13.3/21.7/65
BMI (<18.5/18,5-30/>30) 2/49/9 3.3/81.7/15
Comorbidity (cardiac/ noncardiac/both) 33/26/21 55/43.3/35
COPD stage (0/1/2/3) 27/12/21/0 45/20/35/0
Disease stage (I/II/IIIA/IIIB) 22/28/8/2 36.7/46.7/13.3/3.3
Extent of resection sublobar/ lobectomy/
pneumonectomy.
5/41/14 8.3/68.4/23.3
ns: non smoker; fs: former smoker; cs: current smoker.
Table 2 Postoperative complications
Surgical complications n %
No complications 35 58.3
Air-leak 10 16.7
Pl.effusion, hemothorax, wound problems, B.pl. fistula 15 25
Respiratory complications n %
No complications 48 80
Pneumonia 8 13.4
Atelectasis 4 6.6
Cardiac complications n %
No complications 50 83.4
Atrial fibrillation 9 15
Pulmonary embolism 1 1.6
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2-days intervals by performing in-bed radiographies under
active suction. In patients with a prolonged air leak, the op-
erative chest tubes are always removed after the 7th post-
operative day at maximum, and in case of persisting lung
collapse, a new, narrower caliber chest tube (Fr 18–20
max. diameter) is reinserted. The point of the tube reinser-
tion is selected based on the fluoroscopic aspect.
Postoperative lung function assessment
The trend of the postoperative lung function recovery was
assessed by performing spirometry with a portable spirom-
eter “Viasys Spiro Pro”, with a patient in the sitting position
in bed, with chest tubes connected and under maximal an-
algesia (NSAIDS and tramadol-chloride). Analgetics were
administrated in regular intervals during the first 48-72 h,
followed by administration upon patient’s request.
Measurement of FVC%, FEV1%, VC and PEF 75 was
done on postoperative days one, three and seven.
Data analysis
The following variables were analysed: age, sex, preopera-
tive and postoperative values of FVC%, FEV1%, FEV1%/
FVC%, FEF50, FEF25, pCO2, pO2, DLCO, VO2 max, COPD
index, predicted postoperative FEV1%, postoperative
complications.
In the current study, operative morbidity and mortality re-
ferred to complications or death inside the first 30 postoper-
ative days. Postoperative complications were classified as
respiratory (pneumonia, athelectasis, pulmonary embolism,
respiratory insufficiency and need for prolonged mechanical
ventilation, ARDS/ALI), surgical (prolonged air-leak, postop-
erative bleeding, pleural effusion, empyema, bronchopleural
fistula, operative wound problems) and cardiac (atrial fibril-
lation, myocardial infarction, congestive heart failure).
Criteria for diagnosis of pneumonia were fever, leukocyte
count < 3000 or > 10000, new infiltrates of chest x-ray
and/or positive sputum cultures.
Prolonged air-leak was defined as air-leak longer than
7 postoperative days, regardless of the existence of full
lung expansion under active suction [1].
The described methodology was approved by the Ethical
committee of the University of Belgrade school of medicine.
Statistics
Statistical analysis consisted of nonparametric and para-
metric tests (Mann- Whitney U test, Kruskal-Wallis test,




The structure of the analysed group is presented on
Table 1. The majority of patients - 42(70%) were male,with 39(65%) of them being active smokers at the time
of surgery. The mean/range age for male and female
patients was 60.9 ± 8.4/41-77 and 56.9 ± 6.5/44-68 years
respectively.
Cardiac comorbidities existed in 33(55%), other co-
morbidities (mainly renal, diabetes mellitus, peripheral
vascular) in 26(43.3%) and both cardiac and other co-
morbidities in 21(35%) patients. Body mass index >30
existed in 9(15%) patients. Mild and moderate COPD
according to GOLD criteria, existed in 20% and 35% of
patients respectively.
Based on operative patohistology, almost 80% of patients
were in stages I and II. Most of the patients underwent a
lobectomy, pneumonectomy was done in 14(23.3%), sublo-
bar resection in 5(8.3%) patients.
Preoperative lung function and postoperative
complications
Postoperative complications in the analysed group are
presented on Table 2. Surgical complications were more
frequent than respiratory and cardiac. All registered re-
spiratory and cardiological complications occurred within
the first 7 postopertive days. Air leak, if present at the mo-
ment of the lung function measurement, persisted after
more than 7 postoperative days as well.
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mothorax occurred within the first 3 postoperative days;
and did not require rethoracotomy.
Comparison of patients with surgical, respiratory and
cardiac postoperative complications with patients without
complications, regarding ventilatory function, diffusion,
oxygenation and oxygen consumption, did not confirm sig-
nificant differences (Table 3). Female, compared with male
patients (not presented on table), had significantly higher
preoperative FVC% (98.9 ± 16.28 vs 112.1 ± 23.69), FEV1%
(83.6 ± 18.08 vs 95.9 ± 27.48), COPD index (1.45 ± 0.24 vs.
1.66 ± 0.37) and ppo FEV1% (60.3 ± 15.8 vs 72.2 ± 20.37).
Postoperative changes of ventilatory function
and oxygenation
As presented on Table 4, a clear trend of improvement
of both FVC% and FEV1% was registered in patients
with surgical and respiratory complications, whilst in pa-
tients with cardiac complications, the same trend existed
only the FVC(%). In these patients, beside evident grad-
ual improvement of FEV1, the borderline improve-
ment was registered only between days one and
three. The same trend existed in patients without
postoperative complications.
The trend of the postoperative FEV1 change is pre-
sened on the Figure 1. As can be seen, in patients with
respiratory complications, the improvement between days
three and 7 was greater than in patients of other types of
complications and without complications.
The aforementioned trend existed in patients with lobec-
tomy and pneumonectomy, with no differences depending
of the site of lobectomy (not shown on graph).Table 3 Preoperative lung function parameters in patients wi
With complications
Surgical (1) Respiratory (2)
Mean SD Mean SD
FVC% 102.6 21.36 93.8 18.65
FEV1% 86.6 23.05 81.8 24.40
FEV1%/FVC 68.4 11.23 69.1 11.31
COPD index 1.5 0.29 1.5 0.3
MEF 50 52.2 31.4 51.1 36.05
MEF 25 43.6 30.24 41.5 33.01
ppo FEV1 64.2 20.76 63.2 19.79
pCO2 5.2 0.59 5.3 0.60
pO2 10.8 1.72 10.2 1.2
DLCO 67.1 14.5 71.3 17.37
VO2 max 18.0 6.52 16.0 5.28
FVC%: forced vital capacity expressed in percent; FEV1%: forced expiratory volume
index: index of chronic obstructive pulmonary disease; MEF 50: mean expiratory f
ppo FEV1: predicted postoperative FEV1; pCO2: partial pressure of CO2 in the arter
capacity for carbon monoxide; VO2 max: maximal oxygen consumption.As mentioned before, baseline values for FVC% and
FEV1% were higher in women. Postoperative changes of
these parameters were almost identical in males and fe-
males (not shown on graph).
Concerning oxygenation in the arterial blood, pO2 was
decreasing during the first three postoperative days in a
roughly parallel fashion in patients with respiratory,
surgical complications and in patients without compli-
cations. In patients with cardiac complications, a steep
drop occurred at the moment of the complication onset
(Figure 2). A slight hypercapnia registered on the first
postoperative day was gradually abolished in all groups
except in patients with cardiac complications (Figure 3).
In an attempt to avoid a potential selection bias, we
calculated Thoracoscore both for the analysed group of
patients at high risk and for the well matched control
group of operated patients with a low risk, as assessed
according to the same criteria, and compared these
groups. A significant difference was found between the
groups in relation to Thoracoscore (Table 5).
Discussion
One of the main findings of the current study is a sig-
nificant increase in postoperative FEV1 and FVC values
between days 1. and 3. and between days 3 and 7. irre-
spectively of complications. Such a finding needs to be
discussed from different aspects.
First, such a finding may seem unexpected, having in
mind that the air leak, occurring in up to 21.7% pts after
lobectomy, irrespectively of the performed technique,
usually reaches its maximum just during the first 3–4





Mean SD Mean SD
102.8 20.23 104.0 18.88 1,2,3 vs. 4 > 0.05
86.8 21.47 87.3 20.31 1,2,3 vs. 4 > 0.05
67.7 7.99 69.0 10.99 1,2,3 vs. 4 > 0.05
1.5 0.25 1.5 0.31 1,2,3 vs. 4 > 0.05
47.3 32.71 49.1 21.77 1,2,3 vs. 4 > 0.05
38.8 26.82 40.9 18.74 1,2,3 vs. 4 > 0.05
60.6 21.40 63.0 13.94 1,2,3 vs. 4 > 0.05
5.0 0.67 5.3 0.55 1,2,3 vs. 4 > 0.05
9.9 0.91 10.4 0.97 1,2,3 vs. 4 > 0.05
71.7 20.10 72.5 18.37 1,2,3 vs. 4 > 0.05
17.4 3.54 17.2 4.82 1,2,3 vs. 4 > 0.05
in the 1 second expressed in percent; FEV1%/FVC: as just explained; COPD
low at 50% vital capacity; MEF 25: mean expiratory flow at 25% vital capacity;
ial blood; pO2: partial pressure of O2 in the arterial blood; DLCO: diffusing




Postoperative day P value
1 3 7
Mean SD Mean SD Mean SD
Surgical FVC(%) 48.0 17.46 57.2 17.6 69.5 21.87 d1:3: p < 0.001; d3:7: p < 0.001
FEV1(%) 44.0 15.14 52.2 17.59 62.0 21.10 d1:3: p < 0.001; d3:7: p < 0.001
pO2 16.8 5.72 13.5 4.81 12.5 3.52 d1:2 p < 0.05; d2:3 p > 0.05
pCO2 5.6 0.86 5.6 0.68 5.4 0.76 d1:2 p = 0.05; d2:3 p > 0.05
Respiratory FVC(%) 3.87 10.19 46.5 11.0 62.1 15.26 d1:3: p < 0.001; d3:7: p < 0.001
FEV1(%) 38.6 11.47 44.3 13.3 59.5 18.52 d1:3: p < 0.05; d3:7: p < 0.001
pO2 13.8 3.73 13.4 4.62 11.5 3.75 d1:2 p > 0.05; d2:3 p > 0.05
pCO2 5.8 1.08 5.5 0.75 5.4 0.55 d1:2 p > 0.05; d2:3 p > 0.05
Cardiac FVC(%) 46.1 17.31 52.7 19.33 62.9 19.18 d1:3: p < 0.05; d3:7: p < 0.05
FEV1(%) 43.7 13.85 49.9 17.27 58.9 15.65 d1:3: p = 0.05; d3:7: p > 0.05
pO2 17.5 6.18 18.6 8.38 13.2 4.06 d1:2 p > 0.05; d2:3 p < 0.05
pCO2 5.3 0.86 5.5 0.95 5.6 0.93 d1:2 p > 0.05; d2:3 p > 0.05
No complications FVC(%) 53.3 16.69 60.4 18.27 68.7 16.84 d1:3: p < 0.05; d3:7: p < 0.05
FEV1(%) 49.4 12.43 53.5 13.20 61.1 13.98 d1:3: p < 0.05; d3:7: p < 0.001
pO2 17.1 5.28 14.7 4.03 13.2 3.71 d1:2 p < 0.05; d2:3 p > 0.05
pCO2 5.7 0.75 5.6 0.49 5.4 0.65 d1:2 p > 0.05; d2:3 p = 0.05
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improvement is the fact that, in the analysed group, full
lung expansion existed despite the air leak in all patients,
as assessed on the day of operation and on the first post-
operative day by chest radiographies with chest tubes
connected. It can only be speculated whether the suc-
tion, applied to chest tubes, representing our institu-
tional policy, through the decrease of differential pleural
pressure, possibly led to decreased work of breathing,
at least after upper lobectomies, as suggested in someFigure 1 The trend of postoperative FEV1 change in patients
with and without complications. ♦ surgical complications, ■
cardiac complications,▲respiratory complications, ● no complications.recent studies [10]. In the analysed group, the minimally
negative pressure (ranging 10–40 cm H2O) enabling full
apposition of both pleural surfaces, was applied to the
chest tubes.
Second, it was also demonstrated that the site of lobec-
tomy may influence the postoperative pulmonary func-
tion, with the ventilatory function being better preserved
and oxygen consumption being better than predicted
after lower/middle than after upper lobectomy [11]. InFigure 2 The trend of postoperative changes of pO2. ♦ surgical
complications, ■ cardiac complications, ▲respiratory complications,
● no complications.
Figure 3 The trend of postoperative changes of pCO2. ♦ surgical
complications, ■ cardiac complications, ▲respiratory complications,
● no complications.
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the entire group, consisting of both COPD and non
COPD patients and without differences depending of the
site of lobectomy. Results of several reports showing that
the lung function can be better preserved after upper lob-
ectomy in COPD patients [12], can be counterweighted
by recent findings that the observed postoperative loss in
FEV1 may exceed the predicted loss after upper lobecto-
mies in COPD patients [13]. It means that COPD
strongly influences FEV1 at both the early and late terms
after upper lobectomy, so that the exact way of it’s influ-
ence to the early postoperative lung function preser-
vation still has not been fully elucidated. Based on
estimated CT scan tissue density, bullous emphysema was
present in 4 pts. Therefore lung volume reduction effect,
possibly existing in less than 10% of patients in analysed
group, can not be considered as significant contributor to
observed trends in postoperative changes of ventilatory
function parameters.
Third, our finding that the trend of the early ventila-
tory function improvement existed also after pneumon-
ectomy, supports recent suggestions that, in patients
undergoing pneumonectomy, the ppoFEV1 can under-
estimate the actual poFEV1 by an average of 500 ml
[14]. The smaller loss in FEV1 and greater decrease
of hyperinflation after pneumonectomy in COPD vsTable 5 Thoracoscore in the high and low-risk groups
Thoracoscore








2.58 2.59 1.91 3.25
Low
risk
1.02 0.51 0.89 1.16 1077.5 2847.5 0.000non-COPD patients means that prediction of the postop-
erative lung function in candidates for pneumonectomy
with limited lung function, can be done in a similar way
than in COPD patients undergoing a lobectomy: COPD
patients are likely to do a little bit better postoperatively
than predicted [15]. Furthermore, there is widespread be-
lief that sacrifying of the phrenic nerve during pneumon-
ectomy has no major impact to the postoperative lung
function. However, it was convincingly demonstrated
that, in patients with preserved phrenic nerve and nor-
mal diaphragm motion, the postoperative FEV1 was sig-
nificantly better than in patients with either immobile
diaphragm or with paradoxical diaphragm motion [16].
In the analysed group, phrenic nerve function has been
preserved in all patients undergoing pneumonectomy.
Furthermore, in the analysed group, it seems that me-
diastinal displacement towards the operated side after
pneumonectomy did not influence the described trend,
although it could have some impact to the overall venti-
latory performance - as it was shown that, in COPD pa-
tients it has lung volume reduction effect, whilst in non
COPD patients it can cause vicariate emphysema [17].
In the analysed group, major mediastinal displacement
was registered in the first 3–7 postoperative days in 4
out of 16 patients after pneumonectomy.
Finally, one of the factors that could contribute to the
gradually improving trend of the postoperative ventila-
tory function, could be the function of the small airways.
In most studies that confirmed better postoperative lung
function preservation in COPD vs. non-COPD patients,
the preoperative function and response of the small air-
ways to medical treatment was not addressed. We also
recently confirmed the smaller postoperative loss in
FEV1 in COPD vs. non-COPD patients, but only after
significant improvement of the function of the small air-
ways after combined bronchodilator treatment - the
trend that remained unchanged postoperatively [18].
Our finding that the type of postoperative complica-
tions did not alter the same trend of the lung function
improvement during the first 7 postoperative days, could
be of practical benefit and needs particular discussion.
As for the influence of respiratory complications, such
a finding can be explained by the fact that postoperative
athelectasis, that could certainly lead to the impairment
of ventilatory function, existed in only 4 (6.6%) patients
and was efficiently solved by bronchoscopic aspiration.
Air leak, another factor that could lead to inefficient
ventilation, as already mentioned, even when present,
was always associated with expanded lung, meaning that
the pleural pressure remained negative throughout that
period.
Concerning the maintenance of the tend of the venti-
latory function improvement and cardiac complications,
only the newly discovered atrial fibrillation was included
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ated with preexisting cardiac comorbidities (atrial fibril-
lation developed in 8 patients, in only one without
previously known cardiac disease). Higher incidence of
cardiac comorbidities in our group than in some other
reported series, can be partly explained by the fact that
hypertension, present in 22% of pts, was considered as
cardiac comorbidity [19,20]. Significant number of current
(65%) and former smokers (21.7%) also may contribute to
high incidence of cardiac diseases in our patients. Cardiac
complications could influence the postoperative course by
defining the protocol of physiotherapy, switching it to-
wards less intensive, inhalatory treatment. Low number of
patienst with atrial fibrillation in our group supports the
need for further controlled studies of postoperative cardiac
adverse events and lung function recovery on larger pa-
tient samples.
There are no studies specifically addressing adjustment
of VO2 cut-off values according to comorbidity. Cur-
rently, basic cut-off values for VO2 are >75% predicted
(>20 mL · kg ˉ1 · minˉ1) for pneumonectomy whilst
values <35% pred (<10 mL/kg/min) represent a high risk
for any resection [21]. Evidence is still not sufficient to
recommend cut-off values for lobectomy. The obtained
result suggests that even lower than recommended cut-
off value of VO2 can be accepted for pneumonectomy,
in the absence of major cardiac comorbidity. In the
present study, VO2 ≥ 15 mL/kg/min was accepted as a
limit for increased risk for postoperative complications,
irrespectively of the extent of resection. Although the
VO2 reflects the risk of the overall cardiorespiratory risk,
its prediction is usually done in presence of cardiac comor-
bidity and especially in candidates for pneumonectomy.
Measurement of VO2 itself, only in presence of cardiac
comorbidity can also be put into question, because a re-
cent study on 1067 patients in a 4-year period, did not
confirm cardiac comorbidity as a risk factor for operative
morbidity and mortality [22]. Our result that in the ana-
lysed group, a slightly higher number of patients with
VO2 < 15 ml/kg/min and respiratory complications existed,
supports our policy to determine maximal oxygen con-
sumption also in patients with limited respiratory function.
In the analysed group, all patients underwent measurement
of the VO2.
In the analysed group there was no significant difference
in preoperative lung function parameters and oxygenation
between patients with and without complications.
Although this analysis included only patients with in-
creased risk, such a finding may seem quite unexpected.
Given the well established role of preoperative lung
function and oxygenation as risk factors for operative
morbidity [23,24], our results suggest that their influence
may not be dominant in high risk patients. In fact, it
is difficult to compare these data with similar studies,because most of the literature data refer to differences in
complication rates between patients with vs. patients
without respiratory or cardiac comorbidity, not between
subgroups of patients at increased risk.
Study limitations
The analysed group of patients at risk is a quite hetero-
geneous group, consisting of, different risk types, like,
for example, fit patients with previous history of CABG
and an elderly patients with COPD, left ventricle systolic
function and stroke disease. The obtained significant dif-
ference between patients at risk and control group in re-
lation to Thoracoscore, minimizes a potential selection
bias, in the same time favoring a more widespread use of
this score in practice.
Conclusion
In brief, based on the obtained results, it can be con-
cluded that the extent of the lung resection and postop-
erative complications do not necessarily influence the
trend of the lung function recovery after lung resection
for lung cancer.
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